Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Prostate Cancer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Multicentre, randomized study. A total of 280 patients will participate in this study, equally divided between both study groupsMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04302454
- Collaborators
- Dutch Cancer Society
- Investigators
- Principal Investigator: S. Al-Uwini, PhD UMCG
Get Well Soon